covidinfo2022.tk valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: Mediapartners-Google Disallow: User-agent: * Disallow: /search Allow: / Sitemap: http://www.covidinfo2022.tk/sitemap.xml | ||
Meta Tags
| Title | covidinfo2022 |
| Description | Skip to main content Search This Blog covidinfo2022 Posts Pfizer, BioNTech again seek U.S. nod for COVID-19 vaccine boosters in all adults Get link Facebo |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 216.239.32.21 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
covidinfo2022.tk Valuation
|
US$1,194
Last updated: 2022-07-24 15:13:17
covidinfo2022.tk has Semrush global rank of 0. covidinfo2022.tk has an estimated worth of US$ 1,194, based on its estimated Ads revenue. covidinfo2022.tk receives approximately 137 unique visitors each day. Its web server is located in United States, with IP address 216.239.32.21. According to SiteAdvisor, covidinfo2022.tk is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,194 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$33 |
| Yearly Ads Revenue | US$396 |
| Daily Unique Visitors | 9 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| covidinfo2022.tk. | A | 3599 | IP: 216.239.32.21 |
| covidinfo2022.tk. | A | 3599 | IP: 216.239.36.21 |
| covidinfo2022.tk. | A | 3599 | IP: 216.239.38.21 |
| covidinfo2022.tk. | A | 3599 | IP: 216.239.34.21 |
| covidinfo2022.tk. | NS | 300 | NS Record: ns01.freenom.com. |
| covidinfo2022.tk. | NS | 300 | NS Record: ns02.freenom.com. |
| covidinfo2022.tk. | NS | 300 | NS Record: ns03.freenom.com. |
| covidinfo2022.tk. | NS | 300 | NS Record: ns04.freenom.com. |
HtmlToTextCheckTime:2022-07-24 15:13:17
| Skip to main content Search This Blog covidinfo2022 Posts Pfizer, BioNTech again seek U.S. nod for COVID-19 vaccine boosters in all adults Get link Facebook Twitter Pinterest Email Other Apps November 09, 2021 Nov 9 (Reuters) - Pfizer Inc ( PFE.N ) and BioNTech once again requested the U.S. Food and Drug Administration on Tuesday to authorize booster doses of their COVID-19 vaccine for all adults. The FDA in September had authorized Pfizer’s boosters for people aged 65 and above, and other individuals at high risk of being infected because of their jobs, after a panel of expert advisers to the agency rejected Pfizer’s request for authorization of the booster in all individuals aged 16 and above. The panelists suggested the evidence supporting broad approval was inadequate, and they wanted to see more safety data, especially concerning the risk of heart inflammation in younger people after vaccination. Moderna’s booster doses have since been cleared for use in a similar group of |
HTTP Headers
HTTP/1.1 301 Moved Permanently Location: http://www.covidinfo2022.tk/ Date: Thu, 11 Nov 2021 09:54:35 GMT Content-Type: text/html; charset=UTF-8 Server: ghs Content-Length: 225 X-XSS-Protection: 0 X-Frame-Options: SAMEORIGIN HTTP/1.1 200 OK Content-Type: text/html; charset=UTF-8 Expires: Thu, 11 Nov 2021 09:54:35 GMT Date: Thu, 11 Nov 2021 09:54:35 GMT Cache-Control: private, max-age=0 Last-Modified: Wed, 10 Nov 2021 12:56:34 GMT ETag: "fa5998e3-67fd-43eb-87a5-4b2ba535b3ca" X-Content-Type-Options: nosniff X-XSS-Protection: 1; mode=block Content-Length: 0 Server: GSE |
covidinfo2022.tk Whois Information
COVIDINFO2022.TK BV Dot TK Dot TK administrator P.O. Box 11774 1001 GT Amsterdam Netherlands Phone: +31 20 5315725 Fax: +31 20 5315721 E-mail: abuse: abuse@freenom.com, copyright infringement: copyright@freenom.com NS01.FREENOM.COM NS02.FREENOM.COM NS03.FREENOM.COM NS04.FREENOM.COM Your selected domain name is a Free Domain. That means that, according to the terms and conditions of Free Domain domain names the registrant is BV Dot TK Due to restrictions in Dot TK 's Privacy Statement personal information about the user of the domain name cannot be released. ABUSE OF A DOMAIN NAME |